Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT04509986
NCT04509986UnknownNot Applicable

GlobalSurg-CovidSurg Week: Determining the Optimal Timing for Surgery Following SARS-CoV-2 Infection

University of Birmingham0 sites1,000 target enrollmentStarted: October 1, 2020Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
1,000
Primary Endpoint
Post-operative mortality
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Observational study to determine the optimal timing for surgery following SARS-CoV-2 infection and assess key global surgery indicators.

Detailed Description

  • Prospective, observational international cohort study.
  • Any hospital worldwide can participate (including hospitals that have not admitted SARS-CoV-2 infected patients).
  • All patients undergoing a surgical procedure in an operating theatre will be included. All consecutive eligible patients should be included.
  • 7-day data collection period, with follow-up at 30 days after surgery for each patient. However, no changes should be made to normal patient care/ follow-up pathways
  • Primary outcome is 30-day mortality.
  • All collaborators will be included as PubMed-citable co-authors on resulting publications.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Post-operative mortality

Time Frame: 30 days after surgery

Mortality at 30 days after surgery

Secondary Outcomes

  • In-patient mortality(30 days after surgery)
  • Post-operative complications(30 days after surgery)
  • Post-operative pulmonary complications(30 days after surgery)
  • Post-operative venous thromboembolism(30 days after surgery)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials

Active, not recruiting
Not Applicable
Timing of Surgery and the Evolution of Postoperative Outcomes in Breast Cancer Patients Undergoing Surgical Intervention Following Recovery From SARS-CoV-2 InfectionCOVID-19Postoperative ComplicationsBreast Cancer
NCT06319209Fujian Medical University Union Hospital392
Not yet recruiting
Not Applicable
A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 InfectionIntestines CancerPulmonary CancerTraumaFractures, BoneGynecologic DiseaseLiver Cancer
NCT05781581RenJi Hospital50,000
Not yet recruiting
Not Applicable
Main Postoperative Complications After COVID-19Intestines CancerPulmonary CancerTraumaFractures, BoneLiver Cancer
NCT05694949RenJi Hospital100,000
Completed
Not Applicable
Assesment of Complications and Surgery Timing in Postcovid Thoracotomy Patients: Single Center ExperienceThoracotomy
NCT05496478Ankara University71
Not yet recruiting
Not Applicable
Outcomes of Endoscopic Operation in COVID-19 Infection: Cohort Study.COVID-19Surgery-Complications
NCT05685914Peking University Cancer Hospital & Institute200
GlobalSurg-CovidSurg Week | Clinical Trial